Literature DB >> 24980197

Normoxic regulation of HIF-1α in prostate cancer.

Weranja K B Ranasinghe1, Graham S Baldwin1, Arthur Shulkes1, Damien Bolton2, Oneel Patel1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24980197     DOI： 10.1038/nrurol.2013.110-c2

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  15 in total

Review 1.  Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.

Authors:  Yan Xia; Hyun-Kyung Choi; Kyeong Lee
Journal:  Eur J Med Chem       Date:  2012-01-24       Impact factor: 6.514

Review 2.  Hypoxia, notch signalling, and prostate cancer.

Authors:  Laure Marignol; Karla Rivera-Figueroa; Thomas Lynch; Donal Hollywood
Journal:  Nat Rev Urol       Date:  2013-05-28       Impact factor: 14.432

3.  Polymorphism in the hypoxia-inducible factor 1alpha gene may confer susceptibility to androgen-independent prostate cancer.

Authors:  Cindy H Chau; Matthew G Permenter; Seth M Steinberg; Avi S Retter; William L Dahut; Douglas K Price; William D Figg
Journal:  Cancer Biol Ther       Date:  2005-11-11       Impact factor: 4.742

4.  Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1.

Authors:  B H Jiang; G Jiang; J Z Zheng; Z Lu; T Hunter; P K Vogt
Journal:  Cell Growth Differ       Date:  2001-07

5.  Expression of hypoxia-inducible factor 1alpha in human normal, benign, and malignant prostate tissue.

Authors:  Zhenxian Du; Chisato Fujiyama; Yongxin Chen; Zenjiro Masaki
Journal:  Chin Med J (Engl)       Date:  2003-12       Impact factor: 2.628

6.  Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study.

Authors:  Roy Vergis; Catherine M Corbishley; Andrew R Norman; Jaclyn Bartlett; Sameer Jhavar; Michael Borre; Sara Heeboll; Alan Horwich; Robert Huddart; Vincent Khoo; Ros Eeles; Colin Cooper; Matthew Sydes; David Dearnaley; Chris Parker
Journal:  Lancet Oncol       Date:  2008-03-17       Impact factor: 41.316

7.  HIF1alpha isoforms in benign and malignant prostate tissue and their correlation to neuroendocrine differentiation.

Authors:  Nastaran Monsef; Maria Soller; Ioannis Panagopoulos; Per Anders Abrahamsson
Journal:  BMC Cancer       Date:  2010-07-21       Impact factor: 4.430

8.  Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer.

Authors:  Karsten Gravdal; Ole J Halvorsen; Svein A Haukaas; Lars A Akslen
Journal:  Cancer Res       Date:  2009-06-01       Impact factor: 12.701

Review 9.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

10.  The role of hypoxia-inducible factor 1α in determining the properties of castrate-resistant prostate cancers.

Authors:  Weranja K B Ranasinghe; Lin Xiao; Suzana Kovac; Mike Chang; Carine Michiels; Damien Bolton; Arthur Shulkes; Graham S Baldwin; Oneel Patel
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240
View more
  8 in total

1.  Uncovering the influence of the FGFR1 pathway on glioblastoma radiosensitivity.

Authors:  Karen K Sayal; Geoffrey S Higgins; Ester M Hammond
Journal:  Ann Transl Med       Date:  2016-12

2.  Targeting notch in prostate cancer--combination is the key.

Authors:  Laure Marignol
Journal:  Nat Rev Urol       Date:  2014-07-01       Impact factor: 14.432

3.  AKT, a Key Transmitter of HIF-1α and AR Signaling Pathways, Has a Critical Role in the Apigetrin-Mediated Anti-Cancer Effects in Prostate Cancer Cells.

Authors:  You-Kyung Lee; Jung-Eun Kim; Yinzhu Xu; Hengmin Han; Jae-Hyeon Lee; Hyo-Jeong Lee
Journal:  Biomedicines       Date:  2022-06-09

4.  HIF-2α in Resting Macrophages Tempers Mitochondrial Reactive Oxygen Species To Selectively Repress MARCO-Dependent Phagocytosis.

Authors:  Shirley Dehn; Matthew DeBerge; Xin-Yi Yeap; Laurent Yvan-Charvet; Deyu Fang; Holger K Eltzschig; Stephen D Miller; Edward B Thorp
Journal:  J Immunol       Date:  2016-09-26       Impact factor: 5.422

5.  Bone marrow adipocytes promote the Warburg phenotype in metastatic prostate tumors via HIF-1α activation.

Authors:  Jonathan D Diedrich; Erandi Rajagurubandara; Mackenzie K Herroon; Gargi Mahapatra; Maik Hüttemann; Izabela Podgorski
Journal:  Oncotarget       Date:  2016-10-04

6.  PKM2 and HIF-1α regulation in prostate cancer cell lines.

Authors:  Diya Hasan; Elisabetta Gamen; Nafez Abu Tarboush; Yazan Ismail; Oleg Pak; Belal Azab
Journal:  PLoS One       Date:  2018-09-14       Impact factor: 3.240

7.  Transcriptomic Profiling Analysis of Castration-Resistant Prostate Cancer Cell Lines Treated with Chronic Intermittent Hypoxia.

Authors:  Chung Lyul Lee; Minji Lee; Ji Yong Lee; Sin-Hyoung Hong; Seung Woo Yang; Ji-Hyeon Min; Dong-Eon Lee; Joonyoung Baek; Chanseul Kim; Jae Sung Lim; Ki Hak Song; Ju Hyun Shin; Gun-Hwa Kim
Journal:  Cancers (Basel)       Date:  2022-08-16       Impact factor: 6.575

8.  Adipocyte-Derived Extracellular Vesicles Promote Prostate Cancer Cell Aggressiveness by Enabling Multiple Phenotypic and Metabolic Changes.

Authors:  Fabrizio Fontana; Martina Anselmi; Emanuela Carollo; Patrizia Sartori; Patrizia Procacci; David Carter; Patrizia Limonta
Journal:  Cells       Date:  2022-08-03       Impact factor: 7.666
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.